Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Academiae Medicinae Sinicae ; (6): 603-606, 2009.
Article Dans Chinois | WPRIM | ID: wpr-301642

Résumé

<p><b>OBJECTIVE</b>To explore the efficacy of intraperitoneally injected epirubicin (EPI)-loaded poly (d, l)-lactic acid (PLA) microspheres (MS) alone or combined with free epirubicin (FEPI) in treating hepatocellular carcinoma (HCC) in mice.</p><p><b>METHODS</b>Mice that were transplanted with H22 ascites HCC were randomized into seven groups, which were intraperitoneally injected with blank microspheres, normal saline, three different doses of microspheres (9, 18, and 36 mg/kg EPI) , FEPI (9 mg/kg) , and the combination (microspheres with EPI 4.5 mg/kg + FEPI 4.5 mg/kg). The survival time of all animals was recorded. The rates of increase in life span of all the treatment groups were calculated.</p><p><b>RESULTS</b>EPI-PLA-MS significantly prolonged the survival time of HCC mice in a dose-dependent manner, with a maximal tolerated dose (MTD) of 18 - 36 mg/kg. The combination group had the highest average survival time, median survival time, and rate of increase in life span, which were (40.0 +/- 16.9) days, 33.5 days, and 222.58%, respectively.</p><p><b>CONCLUSION</b>EPI-PLA-MS combined with FEPI is highly effective in treating HCC in mice when intraperitoneally injected.</p>


Sujets)
Animaux , Mâle , Souris , Préparations à action retardée , Épirubicine , Utilisations thérapeutiques , Perfusions parentérales , Acide lactique , Tumeurs expérimentales du foie , Traitement médicamenteux , Microsphères , Polyesters , Polymères
2.
Acta Pharmaceutica Sinica ; (12): 376-380, 2007.
Article Dans Anglais | WPRIM | ID: wpr-281890

Résumé

This study is to investigate the effect of curcumin on the induction of glutathione S-transferases (GST) and NADP(H):quinone oxidoreductase (NQO) and explore their possible molecular mechanism. The activity of GST, NQO and cellular reduced glutathione (GSH) content were measured by spectrophotometrical methods. Cellular changes in the distribution of NF-E2 related factor 2 (Nrf2) were detected by Western blotting analysis. Nrf2-AREs (antioxidant-responsive elements) binding activity was examined by electrophoretic mobility shift assay (EMSA). Treatment of HT-29 human colon adenocarcinoma cells with curcumin dramatically induced the activity of GST and NQO at the range of 10-30 micromol x L(-1). Curcumin exposure caused a significant increase in cellular GSH content rapidly as early as 3 h. Moreover, curcumin triggered the accumulation of Nrf2 in nucleus, and increased Nrf2 content in ARE complexes. These results demonstrated that induction of GST and NQO activity by curcumin may be mediated by translocation of transcription factor Nrf2 from cytoplasm to nuclear and increased binding activity of Nrf2-ARE complexes.


Sujets)
Humains , Antinéoplasiques , Pharmacologie , Antioxydants , Métabolisme , Noyau de la cellule , Métabolisme , Curcumine , Pharmacologie , Induction enzymatique , Glutathion , Métabolisme , Glutathione transferase , Métabolisme , Cellules HT29 , NADPH dehydrogenase (quinone) , Métabolisme , Facteur-2 apparenté à NF-E2 , Métabolisme , Éléments de réponse , Transduction du signal
3.
Acta Academiae Medicinae Sinicae ; (6): 690-694, 2006.
Article Dans Chinois | WPRIM | ID: wpr-313705

Résumé

<p><b>OBJECTIVE</b>To study the effectiveness of treating hepatocellular carcinoma (HCC) in mice with locally administered epirubicin-loaded poly( D, L) - lactic acid microspheres (EPI-PLA-MS ).</p><p><b>METHODS</b>EPI-PLA-MS was prepared with double emulsion solvent evaporation technique. Five groups of mice (n = 8 in each group) were intraperitoneally injected with five different doses of free epirubicin (FEPI), and the maximum tolerated dose (MTD) was calculated. Then 15 mice with transplanted subcutaneous H22 HCC were divided into three groups (n = 5), which were respectively intratumorally injected with normal saline (NS), blank microspheres, and EPI-PLA-MS (with 9 mg/kg of EPI). After two weeks the tumors were excised and weighed. Another 15 mice with transplanted H22 ascites HCC were divided into three groups (n = 5), which were intraperitonealy injected with the same drugs, and the increased life span were registered exactly.</p><p><b>RESULTS</b>The MTD of intraperitoneally injected FEPI was 9 mg/kg. The tumour-inhibiting rates was 40.35% and 36.09% when EPI-PLA-MS were administered by intratumoral injection to the mice with subcutaneous H22 HCC. It significantly prolonged the survival time of mice with H22 ascites HCC and the increased life span by 153.49% and 142.22% when EPI-PLA-MS were intraperitoneally administered.</p><p><b>CONCLUSION</b>EPI-PLA-MS is a new sustained-release preparation with high-efficacy and low-toxicity in treating HCC and has shown promising prospects when administered locally.</p>


Sujets)
Animaux , Mâle , Souris , Antibiotiques antinéoplasiques , Préparations à action retardée , Vecteurs de médicaments , Épirubicine , Injections péritoneales , Acide lactique , Pharmacologie , Tumeurs expérimentales du foie , Traitement médicamenteux , Lignées consanguines de souris , Microsphères , Polyesters , Polymères , Pharmacologie
SÉLECTION CITATIONS
Détails de la recherche